Compounds > cyc 202
Page last updated: 2024-09-04

cyc 202 and Invasiveness, Neoplasm

cyc 202 has been researched along with Invasiveness, Neoplasm in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersen, JM; Caffrey, TC; Collisson, EC; Eggers, JP; Grandgenett, PM; High, RR; Hollingsworth, MA; Lewallen, ME; Ouellette, M; Singh, PK; Swanson, BJ; Tremayne, J1
Akli, S; Duong, MT; Hunt, KK; Keyomarsi, K; Liu, W; Lu, Y; Mills, GB; Wei, C; Wingate, HF; Yi, M1
Amin, ND; Demelash, A; Linnoila, RI; McWhite, CD; Naizhen, X; Pant, HC; Rudrabhatla, P; Wang, X1
Coppola, D; Mohapatra, S; Pledger, WJ; Riker, AI1

Other Studies

4 other study(ies) available for cyc 202 and Invasiveness, Neoplasm

ArticleYear
Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Oct-01, Volume: 17, Issue:19

    Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Carcinoma, Pancreatic Ductal; Cell Cycle Proteins; Cell Line, Tumor; Cyclin-Dependent Kinase 5; Disease Progression; Enzyme Activation; Gene Amplification; Genes, ras; Humans; Mutation; Neoplasm Invasiveness; Nerve Tissue Proteins; Pancreatic Neoplasms; Purines; Roscovitine

2011
LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patients.
    PLoS genetics, 2012, Volume: 8, Issue:3

    Topics: Acinar Cells; Animals; Benzenesulfonates; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cyclin E; Cyclin-Dependent Kinase 2; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Mammary Glands, Animal; MAP Kinase Signaling System; Mice; Mice, Nude; Neoplasm Invasiveness; Niacinamide; Phenylurea Compounds; Prognosis; Protein Isoforms; Proto-Oncogene Proteins B-raf; Purines; Pyridines; Retrospective Studies; Roscovitine; Sirolimus; Sorafenib; TOR Serine-Threonine Kinases

2012
Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway.
    Molecular biology of the cell, 2012, Volume: 23, Issue:15

    Topics: Adenocarcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin-Dependent Kinase 5; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; HEK293 Cells; Histone-Lysine N-Methyltransferase; Humans; Lung Neoplasms; Neoplasm Invasiveness; Nerve Tissue Proteins; Purines; Roscovitine; Signal Transduction; Transcription Factors

2012
Roscovitine inhibits differentiation and invasion in a three-dimensional skin reconstruction model of metastatic melanoma.
    Molecular cancer research : MCR, 2007, Volume: 5, Issue:2

    Topics: Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Humans; Melanoma; Models, Biological; Neoplasm Invasiveness; Protein Kinase Inhibitors; Purines; Roscovitine; Skin Neoplasms; Tissue Culture Techniques

2007